Lixte Biotechnology Holdings

LIXT

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-3.57M

EBITDA$-3.57M

EBIT$-3.57M

Pre-tax Income$-4.09M

Net Income$-3.59M

Net Cash$28.88M

Cash Equivalent$2.17M

Total Debt$0

Net Debt$-28.88M

Book Value$1.89M

Net Cash Per Share5.06

Book Value Per Share0.84

Return on Equity (ROE)-433.50%

Return on Assets (ROA)-313.05%

Return on Invested Capital (ROI)-433.50%

Net Profit Margin-1425.00%

Current Ratio3.60

Quick Ratio3.26

Long-Term Debt / Equitynull